General Principles for the Design of Safer Chemicals: Toxicological Considerations for Chemists

ACS Symposium Series

Volumn 640, Issue , 1996, Pages 16-59

  DeVito, Stephen C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343742782     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-1996-0640.ch002     Document Type: Article

References (99)

1. Ariens, E.J. Design of Safer Chemicals. In Drug Design; Ariens, E.J., Ed.; Medicinal Chemistry, A Series of Monographs Volume IX; Academic Press: New York, NY, 1980; pp 1-46.
2. Ariens, E.J.; Simonis, A.M. General Principles of Nutritional Toxicology. In Nutritional Toxicology; Academic Press: New York, NY, 1982; Vol. 1, pp 17-80.
3. Ariens, E.J. Drug Metab. Rev. 1984 15, pp 425-504.
4. Finch, N. Med. Res. Rev. 1981, 1, pp 337-372.
5. Bodor, N. Med. Res. Rev. 1984, 4, pp 449-469.
6. Baumel, I.P. Drug Metab. Rev. 1984, 15, pp 415-424.
7. Safer Chemicals Through Molecular Design, A Symposium, DiCarlo, F.J., Chairman; Drug Metab. Rev., 1984, 15(3-7).
8. Klaassen, C.D.; Rozman, K. In Casarett and Doull's Toxicology. The Basic Science of Poisons, Fourth Edition; Amdur, M.O.; Doull, J.; Klaassen, C.D. Eds.; Pergamon Press: New York, NY, 1991, pp 50-87.
9. Sipes, G.; Gandolfi, J. In ibid, pp 88-126.
10. Benet, L.Z.; Mitchell, J.R.; Sheiner, L.B. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Eighth Edition; Goodman Gilman, A.; Rall, T.W.; Nies, A.S.; Taylor, P. Eds.; Pergamon Press: New York, NY, 1990, pp 3-32.
11. Dethloff, L.A.; In Drug Toxicokinetics; Welling, P.G.; De La Iglesia, F.A., Eds.; Marcel Dekker, Inc.: New York, NY, 1993, pp 195-219.
12. Valberg, P.A.; In Principles of Route-to-Route Extrapolation for Risk Assessment; Gerrity, T.R.; Henry, C.J. Eds.; Elsevier: New York, NY, 1990, pp 61-70.
13. Overton, J.H.; In ibid, pp 71-91.
14. Flynn, G.L.; In ibid, pp 93-127.
15. Bronaugh, R.L.; In ibid, pp 185-191.
16. D'Souza, R.W.; In ibid, pp 173-183.
17. Williams, D.A.; In Principles of Medicinal Chemistry, Third Edition; Foye, W.O. Ed.; Lea & Febiger: Philadelphia, PA, 1989, pp 79-117.
18. Koymans, L.; Donne-Op den Kelder, G.M.; Koppele Te, J.M.; Vermeulen, N.P.E. Drug Metab. Rev., 1995, 25, pp 325-387.
19. Goeptar, A.R.; Scheerens, H.; Vermeulen, N.P.E. Crit. Rev. Toxicol., 1995, 25, pp 25-65.
20. Bioactivation of Foreign Compounds; Anders, M.W., Ed.; Biochemical Pharmacology and Toxicology Series; Academic Press: New York, NY, 1985.
21. Castagnoli, N.; Castagnoli, K.P. Biotransformation of Xenobiotics to Chemically Reactive Metabolites. In Drug Toxicokinetics; Welling, P.G., De La Iglesia, F.A. Eds.; Drug and Chemical Toxicology Series, 9; Marcel Dekker: New York, NY, 1993, pp 43-68.
22. Guengerich, P.F.; Shimada, T. Chem. Res. Toxicol., 1991, 4, pp 391-407.
23. Vermeulen, N.P.E.; Donne-Op den Kelder; Commandeur, J.N.M. Formation of and Protection Against Toxic Reactive Intermediates. In Perspectives in Medicinal Chemistry; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. Eds.; VCH: New York, NY, 1993, pp 573-593.
24. Commandeur, J.N.M.; Vermeulen, N.P.E. Chem. Res. Toxicol., 1990, 3, pp 171-194.
25. Vermeulen, N.P.E.; te Koppele, J.M. Stereoselective Biotransformation. Toxicological Consequences and Implications. In Clinical Pharmacol., 1993, 18 (Drug Stereochemistry, Second Edition), Wainer, I.W. Ed.; pp 245-280.
26. DeCaprio, A.P. In Selectivity and Molecular Mechanisms of Toxicity. DeMatteis, F.; Lock, E.A. Eds.; MacMillan Press: New York, NY, 1987, pp 249-263.
27. Chung, F-L.; Tanaka, T.; Hecht, S.S. Cancer Res., 1986, 46, pp 1285-1289.
28. Karol, M.H.; Jin, R. Chem. Res. Toxicol. 1991, 4, pp 503-509.
29. Hemminki, K.; Falck, K.; Vaino, H. Arch. Toxicol., 1980, 46, pp 277-285.
30. Sipes, G.I.; Gandolfi, A.J. In Casarett and Doull's Toxicology. The Basic Science of Poisons, Third Edition, Klaassen, C.D.; Amdur, M.O.; Doull, J. Eds.; MacMillan Press: New York, NY, 1986, pp 94-95.
31. U.S. Environmental Protection Agency. New Chemicals Program Categories of Concern (revised February, 1992). U.S. EPA, Washington, D.C. Available through the TSCA Assistance Information Service, U.S. EPA (TS-799), 401 M Street, S.W., Washington, DC 20460 (phone 202-554-1404).
32. Lipnick, R.L. Sci. Total Environ., 1991, 109/110, pp 131-153.
33. Seventh Annual Report on Carcinogens. 1994. U.S. Dept. of Health and Human Services, National Toxicology Program. Research Triangle Park, N.C.
34. Osman, R.; Namboodiri, K.; Weinstein, H.; Rabinowitz, J.R. J. Am. Chem. Soc., 1988, 110, pp 1701-1707.
35. 1 Mice (Gavage Studies). 1986. U.S. Dept. of Health and Human Services, National Toxicology Program. Research Triangle Park, N.C.
36. 1 Mice (Inhalation Studies). 1986. U.S. Dept. of Health and Human Services, National Toxicology Program. Research Triangle Park, N.C.
37. Coles, B. Drug Metab. Rev. 1984-85, 15, pp 1307-1334.
38. Thompson, D.C.; Thompson, J.A.; Sugumaran, M.; Moldeus, P. Chem-Biol. Interactions 1992, 86, pp 129-162.
39. Bolton, J.L.; Valerio, L.G.; Thompson, J.A. Chem. Res. Toxicol. 1992, 5, pp 816-822.
40. Mizutani, T.; Nomura, H.; Nakanishi, K.; Fujita, S. Toxicol. Applied Pharmacol. 1987, 87, pp 166-176.
41. Mizutani, T.; Ishida, I.; Yamamoto, K.; Tajima, K. Toxicol. Applied Pharmacol. 1982, 62, pp 273-281.
42. Bolton, J.L.; Sevestre, H.; Ibe, B.O.; Thompson, J.A. Chem. Res. Toxicol. 1990, 3, pp 65-70.
43. Thompson, D.C.; Perera, K.; Krol, E.S.; Bolton, J.L. Chem. Res. Toxicol. 1995, 8, pp 323-327.
44. Thompson, D.C.; Perera, K.; Fisher, R.; Brendel, K. Toxicol. Applied Pharmacol. 1994, 125, pp 51-58.
45. Thompson, D.C.; Perera, K.; London, R. Chem. Res. Toxicol. 1995, 8, pp 55-60.
46. Lipnick, R.L.; Johnson, D.E.; Gilford, J.H.; Bickings, C.H.; Newsome, L.D. Environ. Toxicol. Chem. 1985, 4, pp 281-296.
47. Lipnick, R.L.; Watson, K.R.; Strausz, A.K. Xenobiotica 1987, 17, pp 1011-1025.
48. DeMaster, E.G.; Dahlseid, T.; Redfern, B. Chem. Res. Toxicol. 1994, 7, pp 414-419.
49. Tsai, R-S.; Carrupt, P-A.; Testa, B.; Caldwell, J. Chem. Res. Toxicol. 1994, 7, pp 73-76.
50. Wilkinson, C.F.; Murray, M. Drug Metab. Rev. 1984, 15, pp 897-917.
51. Ortiz de Montellano, P.R. Alkenes and Alkynes. In Bioactivation of Foreign Compounds; Anders, M.W., Ed.; Biochemical Pharmacology and Toxicology Series; Academic Press: New York, NY, 1985, pp 121-155.
52. Henschler, D. Halogenated Alkenes and Alkynes. In ibid, pp 317-347.
53. Fischer, I.U.; von Unruh, G.E.; Dengler, H.J. Xenobiotica, 1990, 20, pp 209-222.
54. Trush, M.A.; Mimnaugh, E.G.; Gram, T.E. Biochem. Pharmacol., 1982, 21, pp 3335-3346.
55. Clark, I.A.; Cowden, W.B.; Hunt, N.H. Med. Res. Rev. 1985, 5, pp 297-332.
56. Aust, S.D.; Chignell, C.F.; Bray, T.M.; Kalyanaraman, B.; Mason, R.P. Toxicol. Appl. Pharmacol. 1993, 120, pp 168-178.
57. Goldstein, B.D. Hematotoxicity in Humans. In Benzene Toxicity: A Critical Evaluation; Laskin, S., Goldstein, B.D., Eds.; McGraw-Hill: New York, NY, 1977, pp 69-105.
58. Rinski, R.A.; Smith, A.B.; Hornung, R.; Filloon, T.G.; Young, R.J.; Okun, A.H.; Landrigan, P.J. N. Engl. J. Med. 1987, 316, pp 1044-1050.
59. Sammett, D.; Lee, E.W.; Kocsis, J.J.; Snyder, R. J. Toxicol. Environ. Health, 1979, 5, pp 785-792.
60. Andrews, L.S.; Snyder, R. In Casarett and Doull's Toxicology. The Basic Science of Poisons; Amdur, M.O., Doull, J., Klaassen, C.D., Eds.; Pergamon Press: New York, NY, 1991, 4th Edition, pp 685-690.
61. Chapman, D.E.; Moore, T.J.; Michener, S.R.; Powis, G. Drug Metab. Dispos. 1990, 18, pp 929-936.
62. Reference 60, pp 705-708.
63. DeCaprio, A. Neurotoxicology, 1987, 8, pp 199-210.
64. Serve, M.P.; Bombick, D.D.; Roberts, J.; McDonald, G.A.; Matie, D.R.; Yu, K.O. Chemosphere, 1991, 22, pp 77-84.
65. Burger, A. A Guide to the Chemical Basis of Drug Design. John Wiley and Sons, Inc.:New York, NY 1983.
66. Auer, C.M.; Nabholz, J.V.; Baetcke, K.P. Environ. Health Perspect. 1990, 87, pp 183-197.
67. Unpublished (in-house) data. United States Environmental Protection Agency. Office of Pollution Prevention and Toxics, Washington, DC, 20460.
68. Doerge, D.R.; Takazawa, R.S. Chem. Res. Toxicol. 1990, 3, pp 98-101.
69. Christian, J.D. Imidazolidinethiones. U.S. Patent 2,842,553. July 8, 1958. Monsanto Chemical Company. (See Chemical Abstract 52:20202c).
70. Christian, J.D. Imidazolidinethiones. U.S. Patent 2,842,553. July 8, 1958. Monsanto Chemical Company. (See Chemical Abstract 52:20202c).
71. Haynes, R.C. Thyroid and Antithyroid Drugs. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, Eighth Edition; Goodman Gilman, A.; Rail, T.W.; Nies, A.S.; Taylor, P. Eds.; Pergamon Press: New York, NY, 1990, pp 1373-1377.
72. Kumamoto, T.; Toyooka, K.; Nishida, M.; Kuwahara, H.; Yoshimura, Y.; Kawada, J.; Kubota, S. Chem. Pharm. Bull. 1990, 38, pp 2595-2596.
73. Kassahun, K.; Farrell, K.; Abbott, F. Drug Metab. Dispo. 1991, 19, pp 525-534.
74. Camper, D.L.; Loew, G.H.; Collins, J.R. Int. J. Quantum Chem., Quantum Biol. Symp. 1990, 17, pp 173-187.
75. Narotsky, M.G.; Francis, E.Z.; Kavlock, R.J. Fundam. Appl. Toxicol. 1994, 22, pp 251-265.
76. DiCarlo, F.J.; Bickart, P.; Auer, C.M. Drug Metab. Rev. 1986, 17, pp 187-220.
77. DiCarlo, F.J. Drug Metab. Rev. 1990, 22, pp 411-449.
78. ECOSAR. A Computer Program for Estimating the Ecotoxicity of Industrial Chemicals Based on Structure-Activity Relationships. To obtain a copy of ECOSAR, contact; ECOSAR Program, Environmental Effects Branch, Health and Environmental Review Division (7403), U.S. Environmental Protection Agency, 401 M St., SW, Washington DC, 20460.
79. Martin, Y.C. Quantitative Drug Design; Medicinal Research Series No. 8; Marcel Dekker, Inc.: New York, NY, 1978.
80. Quantitative Drug Design; Ramsden, C.A. Ed. In Comprehensive Medicinal Chemistry, Pergamon Press: New York, NY 1990; Vol. 4.
81. Burger's Medicinal Chemistry and Drug Discovery; Volume 1, Principles and Practice; Wolff, M.E. Ed. Wiley: New York, NY 1994.
82. Exploring QSAR; Volume 1, Fundamentals and Applications in Chemistry and Biology; Hansch, C.; Leo, A. Eds. American Chemical Society, Washington DC, 1995.
83. Exploring QSAR; Volume 2, Hydrophobic, Electronic and Steric Constants; Hansch, C.; Leo, A.; Hoekman, D. Eds. American Chemical Society, Washington DC, 1995.
84. Practical Applications of Quantitative Structure-Activity Relationships (QSAR) in Environmental Chemistry and Toxicology; Karcher, W.; Devillers, J. Ed. Kluwar Academic Publishers: Boston, MA 1990.
85. Langmuir, I. J. Am. Chem. Soc., 1919, 41(868), pp 1543-
86. Burger, A. Progress Drug Res., 1991, 37, pp 287-371.
87. Burger, A. Med. Chem. Res., 1994, 4, pp 89-92.
88. Biochemistry for the Medical Sciences. Newsholme, E.A.; Leech, A.R., Eds. Wiley: New York, NY 1983. pp 100-103.
89. Freeman, H.S.; Sokolowska-Gajda, J.; Reife, A. Int. Conf. Exhib., American Association of Textile Chemists and Colorists, 1993, pp 254-259. (See Chemical Abstracts, 121:159353).
90. Freeman, H.S.; Sokolowska-Gajda, J.; Reife, A. Int. Conf. Exhib., American Association of Textile Chemists and Colorists, 1993, pp 254-259. (See Chemical Abstracts, 121:159353).
91. Sokolowska-Gajda, J.; Freeman, H.S.; Reife, A. Text. Res. J., 1994, 64(7), pp 388-396.
92. Sieburth, S. McN.; Manly, C.J.; Gammon, D.W. Pestic. Sci., 1990, 28, pp 289-307.
93. Sieburth, S. McN.; Langevine, C.N.; Dardaris, D.M. Pestic. Sci., 1990, 28, pp 309-319.
94. Bodor, N. Chemtech, October 1995, pp 22-32.
95. DePompei, M.F. Non Isocyanate Sealants. In Preprints of Papers Presented atthe 208th American Chemical National Meeting, 1994, pp 393-394 (paper no. 276).
96. Czajkowski, W. Dyes Pigm., 1991, 17, pp 297-301.
97. Clarke, E.A. Drug Metab. Rev. 1984, 15, pp 997-1009.
98. Donohue, M.D.; Geiger, J.L. Reduction of VOC Emission During Spray Painting Operations: A New Process Using Supercritical Carbon Dioxide. In Preprints of Papers Presented at the 208th American Chemical National Meeting, 1994, pp 218-219 (paper no. 54).
99. Benign by Design, Alternative Synthetic Design for Pollution Prevention; Anastas, P.T.; Farris, C.A., Eds.; American Chemical Society Symposium Series 577; American Chemical Society: Washington, DC, 1994.